Firm Delays Muscular Dystrophy Drug Launch Amid Criticism of $89,000 Price

Marathon Pharmaceuticals will delay the U.S. launch of its muscular dystrophy drug amid mounting criticism of its $89,000-a-year price, including from two members of Congress who launched an investigation Monday.
Source: WSJ.com: Health - Category: Pharmaceuticals Tags: FREE Source Type: news